MedPath

Triclosan, Triclocarban, and the Microbiota

Not Applicable
Completed
Conditions
Triclosan Effects on Microbial Flora
Interventions
Other: triclosan/triclocarban-containing personal care products
Registration Number
NCT01509976
Lead Sponsor
Stanford University
Brief Summary

Triclosan (5-chloro-2 (22,4-dichlorophenoxy)phenol) is a broad-spectrum antibacterial and antifungal agent that is found in thousands of common household products, including deodorants, toothpaste, "antibacterial" soaps, cleaning products, kitchen utensils, bedding, socks, trash bags. The benefits of triclosan have not been proven except in reducing plaque and gingivitis when used in toothpaste. In this study, the investigators intend to look at whether exposure to triclosan changes the colonizing flora of the skin, gut and mouth as well as changes in certain blood hormone levels, including adipocytokines, androgens, and inflammatory markers. Changes in the gut microbiota have been associated with a variety of disease states such as inflammatory bowel disease, colorectal cancer. Additionally, reductions in the microbiome diversity have been associated with obesity.

Detailed Description

Hypothesis: Exposure to triclosan changes microbial flora and leads to changes in

Objectives:

1. Assess diversity and quantities of microbial flora in gut, skin, mouth before, during, and after TC use

2. Assess whether TC use correlates with microbial resistance

3. If any, assess time to change in alterations in microbial flora

Study design:

Prospective, randomized, double-blinded, cross-over study of 20 subjects

Here, we propose a pilot study in which we will compare the microbial flora of subjects who use triclosan-containing personal hygiene products and those who use triclosan-free products. We will randomize half the cohort to triclosan-containing personal hygiene products including toothpaste, liquid hand soap, bar soap, and dish soap for half of the cohort for a 5-month period of time. The participants and investigators will be blinded as to whether they are using triclosan-containing products or triclosan-free products by blinding the packaging. After about 5 months, the participants will cross-over to the other arm.

During a lead-in period of about 2 weeks, we will collect urine samples for a baseline triclosan level and body weight. We will also collect Leptin, Resistin, Grehlin, IL 10, IL17, PAI-1 Plasminogen activator inhibitor -1, TNFa, IFN-g, Insulin, IGF, Glucagon, CRP, TSH, Free T4T3, Estradiol, Testosterone free, Testosterone total, Adiponectin, IL6, Visfatin, H. pylori, ESR. Blood, urine, and body weight will be collected at three points in the study: prior to first phase, in between phases, and after completion of second phase.

We will collect stool, skin, tooth, and saliva samples multiple times throughout the study and submit for pyrosequencing.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Health subjects
  • Age >18 years
Read More
Exclusion Criteria
  • Pregnancy
  • Recent travel to the developing world (within 3 months)
  • Recent use of antibiotics (within 3 months)
  • Unwillingness to change personal care/hygiene products
  • Recent gastrointestinal illness (within 3 months)
  • Individuals who are unlikely to be available for the 10 months of the study period.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Bluetriclosan/triclocarban-containing personal care productsThis arm will either start with personal care products that contain triclosan and then and cross over to personal care products that do not contain triclosan or vice-versa. Since the investigators are blinded, it is not clear which arm is which.
Redtriclosan/triclocarban-containing personal care productsThis arm will either start with personal care products that contain triclosan and then and cross over to personal care products that do not contain triclosan or vice-versa. Since the investigators are blinded, it is not clear which arm is which.
Primary Outcome Measures
NameTimeMethod
Changes in microbial flora5 months in each phase for a total of 10 month study period

We will assess diversity and quantities of microbial flora in gut, skin, mouth before, during, and after triclosan use.

Time to alteration in flora.5 months in each phase for a total of 10 month study period

We will assess time to change in alterations in microbial flora, if any.

Microbial resistance5 months in each phase for a total of 10 month study period

We will assess whether triclosan use correlates with microbial resistance

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath